Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centrus Energy Corp (LEU) vs Revvity Inc (RVTY) Price & Performance

Centrus Energy CorpTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Centrus Energy Corp vs Revvity Inc — how do they compare? Centrus Energy Corp trades at $170.5 (market cap $3.08B), while Revvity Inc trades at $110.35 (market cap $11.87B). The key difference: Revvity Inc is far larger — about 3.9× Centrus Energy Corp's market cap, and Revvity Inc pays a 0.26% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.

LEURVTY
Market Cap
$3.08B$11.87B
Sector
EnergyTechnology
52-Week High
$436.00$117.75
52-Week Low
$146.61$82.26
Enterprise Value
$2.39B$14.36B
Dividend Yield
0.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centrus Energy Corp

Centrus Energy (LEU) trades at $156.39, showing modest daily gains amid a bearish technical outlook. The company reported mixed quarterly earnings, with a recent beat in Q1 2026 but misses in prior quarters. Positive developments include a $1 billion+ DOE contract and inclusion in the S&P SmallCap 600, highlighting its strategic role in the U.S. nuclear fuel supply chain. Valuation ratios remain elevated, with a P/E of 56.75, while profitability metrics like a 13.4% net income margin reflect solid operational performance.

The outlook for LEU is cautiously optimistic, driven by government contracts and nuclear energy tailwinds, but high valuation and recent earnings volatility pose risks. Analyst consensus is mixed with a $223.14 price target, suggesting potential upside if execution improves. Key risks include dependency on federal contracts and competitive pressures in the uranium sector.

Revvity Inc

RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.

The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centrus Energy Corp

Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.

Read more on LEU

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY